ODI Pharma AB: Publication of half-year report 2020
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2020. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Second quarter (2020-10-01 – 2020-12-31) The Group's net sales amounted to SEK 0 (72,741). The Group's loss after financial items amounted to SEK -771,779 (-1,401,276). Result per share amounted to SEK -0.05 (-0.11).* The solidity as of 2020-12-31 was 98% (80).** First six months (2020-07-01 – 2020-12-31) The